Japan's Astellas to buy Audentes for $3 billion in gene therapy push

Japan's Astellas to buy Audentes for $3 billion in gene therapy push

Submitted by admin on December 2, 2019 - 11:58pm
Source: 
Reuters
News Tags: 
Astellas
M&A
gene therapy
Audentes Therapeutics
Headline: 
Japan's Astellas to buy Audentes for $3 billion in gene therapy push
snippet: 

Japan’s Astellas Pharma Inc (4503.T) has agreed to buy Audentes Therapeutics Inc (BOLD.O) for about $3 billion in cash as it seeks to make genetic medicines a key area of growth.

Do Not Allow Advertisers to Use My Personal information